Health and Healthcare

Incyte : INCY

All Incyte Articles

136 Articles

Chris Lange | Mar 8, 2018 at 11:50 AM EST

Merrill Lynch’s Top Biotech Acquisition Targets in 2018

Merrill Lynch has taken a look at the biotech industry and made a few picks that could play out in…

Chris Lange | Jan 11, 2018 at 4:10 PM EST

Thursday’s Biggest Winners and Losers in the S&P 500

Thursday was a strong day for the U.S. markets, with all three of the major exchanges hitting all-time highs yet…

Jon C. Ogg | Jan 2, 2018 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney, Windstream and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM,…

Chris Lange | Dec 30, 2017 at 8:55 AM EST

30 Big Biotech Events Coming in 2018

Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock…

Jon C. Ogg | Dec 6, 2017 at 10:05 AM EST

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately,…

Chris Lange | Nov 20, 2017 at 4:44 PM EST

Monday’s Biggest Winners and Losers in the S&P 500

Monday was a relatively positive day for the three major U.S. exchanges, but trading volumes were low as this is…

Paul Ausick | Aug 30, 2017 at 4:13 PM EDT

Wednesday’s Biggest Winners and Losers Among the S&P 500

The S&P 500 index closed up about 0.5% Wednesday on a day that saw all three major indexes finish on…

Chris Lange | Jun 5, 2017 at 4:06 PM EDT

Monday’s Biggest Winners and Losers in the S&P 500

Overall Monday was a relatively flat day for the broad markets. Despite crude oil sliding lower on the day, Oil…

Chris Lange | Jun 5, 2017 at 9:45 AM EDT

7 ASCO Stocks Moving on Cancer Study News (Updated)

The Annual Meeting for the American Society of Clinical Oncology (ASCO) is currently underway in Chicago, and the health care…

Chris Lange | Jun 2, 2017 at 1:35 PM EDT

15 Companies Bracing for Big ASCO Reactions

24/7 Wall St. takes a look at the ASCO annual meeting each year and picks out the companies that could…

Chris Lange | May 18, 2017 at 4:08 PM EDT

Thursday’s Biggest Winners and Losers in the S&P 500

Although Wednesday was the worst trading day that the markets have seen in 2016, Thursday the broad markets made a…

Jon C. Ogg | May 12, 2017 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Ambac, Bed Bath & Beyond, GE, Tiffany, Trade Desk and Many More

The top analyst upgrades, downgrades and other research calls on Friday include Ambac, Bed Bath & Beyond, General Electric, Tiffany…

Jon C. Ogg | Apr 17, 2017 at 10:20 AM EDT

FDA Delivers Big Rheumatoid Athritis Disappointment for Eli Lilly and Incyte

When drugs are expected to get FDA approval and show positive data but don't, the underlying stocks of drug and…

Jon C. Ogg | Apr 17, 2017 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Canadian Solar, Constellation Brands, Eli Lilly, Incyte, McDonald’s, Snap and More

The top analyst upgrades, downgrades and initiations seen from Monday include Canadian Solar, Constellation Brands, Eli Lilly, Incyte, McDonald's and…

Lee Jackson | Apr 15, 2017 at 9:20 AM EDT

Analysts See 10 Companies Beating Expectations This Earnings Season

With earnings starting to really snowball next week, and a market that seems to be teetering somewhat due to high…

1 2 3 4 5 6 … 10

Incyte : INCY

All Incyte Articles

Merrill Lynch’s Top Biotech Acquisition Targets in 2018

Thursday’s Biggest Winners and Losers in the S&P 500

Top Analyst Upgrades and Downgrades: Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney, Windstream and More

30 Big Biotech Events Coming in 2018

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Monday’s Biggest Winners and Losers in the S&P 500

Wednesday’s Biggest Winners and Losers Among the S&P 500

Monday’s Biggest Winners and Losers in the S&P 500

7 ASCO Stocks Moving on Cancer Study News (Updated)

15 Companies Bracing for Big ASCO Reactions

Thursday’s Biggest Winners and Losers in the S&P 500

Top Analyst Upgrades and Downgrades: Ambac, Bed Bath & Beyond, GE, Tiffany, Trade Desk and Many More

FDA Delivers Big Rheumatoid Athritis Disappointment for Eli Lilly and Incyte

Top Analyst Upgrades and Downgrades: Canadian Solar, Constellation Brands, Eli Lilly, Incyte, McDonald’s, Snap and More

Analysts See 10 Companies Beating Expectations This Earnings Season

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

Incyte : INCY

All Incyte Articles

Merrill Lynch’s Top Biotech Acquisition Targets in 2018

Thursday’s Biggest Winners and Losers in the S&P 500

Top Analyst Upgrades and Downgrades: Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney, Windstream and More

30 Big Biotech Events Coming in 2018

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Monday’s Biggest Winners and Losers in the S&P 500

Wednesday’s Biggest Winners and Losers Among the S&P 500

Monday’s Biggest Winners and Losers in the S&P 500

7 ASCO Stocks Moving on Cancer Study News (Updated)

15 Companies Bracing for Big ASCO Reactions

Thursday’s Biggest Winners and Losers in the S&P 500

Top Analyst Upgrades and Downgrades: Ambac, Bed Bath & Beyond, GE, Tiffany, Trade Desk and Many More

FDA Delivers Big Rheumatoid Athritis Disappointment for Eli Lilly and Incyte

Top Analyst Upgrades and Downgrades: Canadian Solar, Constellation Brands, Eli Lilly, Incyte, McDonald’s, Snap and More

Analysts See 10 Companies Beating Expectations This Earnings Season

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s